| 0.6 |
1.7 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.6 |
2.3 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 |
1.4 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
1.0 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.3 |
2.0 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
2.4 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
1.1 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 |
0.8 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.2 |
1.2 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 |
0.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.7 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
0.2 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.2 |
0.6 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 |
0.9 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
0.7 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
0.5 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.2 |
1.0 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
0.5 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
0.5 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 |
0.5 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.1 |
0.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.1 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 |
0.4 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 |
1.0 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.6 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.1 |
0.3 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.6 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.1 |
0.1 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.1 |
0.1 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.1 |
0.4 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 |
0.3 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 |
0.3 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
0.2 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
1.5 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.9 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.3 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.1 |
1.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
0.5 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 |
0.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
1.0 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.3 |
GO:0048865 |
stem cell fate commitment(GO:0048865) |
| 0.1 |
0.4 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
0.5 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.6 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.1 |
0.1 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.1 |
0.3 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.5 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.1 |
0.7 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.4 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
1.2 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
0.3 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.1 |
1.6 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.6 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.8 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.9 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.3 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.6 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.1 |
0.8 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.2 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 |
0.2 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.2 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.3 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.1 |
0.2 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 |
0.1 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 |
1.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.2 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.1 |
1.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.2 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 |
0.4 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.2 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.1 |
0.6 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
0.3 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.1 |
0.4 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.9 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.4 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.2 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.1 |
0.2 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.2 |
GO:0090294 |
nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.1 |
0.2 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.4 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 |
0.5 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.6 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.1 |
0.3 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
2.1 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.1 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
0.1 |
GO:0038129 |
ERBB3 signaling pathway(GO:0038129) |
| 0.1 |
0.7 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.9 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.2 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 |
0.1 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.1 |
0.2 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.1 |
0.3 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
0.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 |
0.4 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.1 |
0.2 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.2 |
GO:0061349 |
chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.1 |
0.8 |
GO:0070255 |
regulation of mucus secretion(GO:0070255) |
| 0.1 |
0.2 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.1 |
0.2 |
GO:1903722 |
negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
| 0.1 |
0.2 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.2 |
GO:1990927 |
vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.1 |
1.2 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 |
0.2 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.4 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.4 |
GO:1902162 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 |
0.2 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.1 |
0.4 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.3 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.3 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 |
0.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.2 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 |
0.3 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.4 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.1 |
0.4 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.1 |
0.2 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.1 |
1.4 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.2 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.3 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.1 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 |
0.2 |
GO:0032900 |
negative regulation of neurotrophin production(GO:0032900) |
| 0.1 |
0.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.3 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.4 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.1 |
0.4 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
1.3 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.2 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.0 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.1 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.0 |
0.4 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.1 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.1 |
GO:0031106 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.0 |
0.1 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.0 |
0.6 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.8 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.0 |
0.2 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
1.0 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.0 |
0.8 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 |
0.2 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.0 |
0.2 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.1 |
GO:1900114 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.0 |
0.1 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.0 |
0.2 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.0 |
0.4 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.0 |
0.1 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.0 |
0.4 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 |
0.1 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 |
1.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.6 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.1 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.3 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.0 |
0.2 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.2 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.0 |
0.1 |
GO:0002881 |
microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.2 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.5 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.8 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.0 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
0.3 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.6 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.2 |
GO:0061324 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.0 |
0.8 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.1 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 |
0.2 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.0 |
0.4 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.0 |
0.2 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.4 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.3 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.0 |
0.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.1 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.1 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.0 |
1.0 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.1 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.0 |
1.3 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.2 |
GO:0071158 |
regulation of cell cycle arrest(GO:0071156) positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.3 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.0 |
0.9 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 |
0.1 |
GO:0034239 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) positive regulation of osteoclast proliferation(GO:0090290) |
| 0.0 |
0.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.4 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 |
0.3 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 |
0.0 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.0 |
0.2 |
GO:0051549 |
positive regulation of keratinocyte migration(GO:0051549) |
| 0.0 |
0.3 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.0 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
1.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.2 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 |
0.1 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.0 |
0.5 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.0 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.0 |
0.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.1 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.0 |
0.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.0 |
1.0 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.2 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.0 |
0.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.0 |
GO:0015838 |
quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.0 |
0.2 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.3 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.0 |
0.2 |
GO:1903597 |
regulation of renal output by angiotensin(GO:0002019) negative regulation of gap junction assembly(GO:1903597) |
| 0.0 |
1.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.1 |
GO:0016237 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
| 0.0 |
0.2 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.0 |
0.5 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.3 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
0.0 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 |
0.2 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.0 |
0.1 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.0 |
0.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 |
0.2 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 |
0.0 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.1 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.0 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.1 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.2 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.1 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.0 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.1 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.0 |
0.2 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.0 |
0.2 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 |
0.2 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.1 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.0 |
0.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.1 |
GO:0048489 |
synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
| 0.0 |
0.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.6 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.0 |
0.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 |
0.1 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.0 |
0.2 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.0 |
0.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.4 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.0 |
0.3 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.1 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.0 |
0.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.2 |
GO:0002729 |
positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.0 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.2 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.0 |
0.3 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.0 |
0.1 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.0 |
0.1 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.1 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.0 |
0.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
1.3 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.1 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.0 |
0.1 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.2 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.0 |
0.3 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.0 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.3 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.1 |
GO:0010901 |
regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 0.0 |
0.4 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.1 |
GO:0051140 |
regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.0 |
0.1 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.4 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.0 |
0.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.0 |
0.0 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.4 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.4 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.0 |
0.3 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.0 |
0.1 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.1 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 |
0.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.2 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.2 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.1 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.1 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.0 |
0.1 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.0 |
0.1 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.0 |
0.2 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.0 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 |
0.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.1 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.0 |
0.1 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.0 |
0.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.2 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.1 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.7 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
1.7 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.7 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.1 |
GO:0050926 |
regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.3 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 |
0.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.4 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.0 |
0.5 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.0 |
0.2 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.0 |
0.1 |
GO:0097473 |
cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.0 |
0.1 |
GO:0070839 |
interleukin-3 production(GO:0032632) divalent metal ion export(GO:0070839) |
| 0.0 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.1 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.0 |
0.5 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.1 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.0 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.3 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.4 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.2 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.5 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.0 |
0.2 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.1 |
GO:1902460 |
transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 |
0.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.1 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.0 |
1.5 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.2 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.2 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.1 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.2 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.2 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.1 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 |
0.4 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.1 |
GO:0046056 |
dADP metabolic process(GO:0046056) |
| 0.0 |
0.1 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.0 |
0.2 |
GO:0032888 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.1 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.0 |
0.1 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.2 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 |
0.2 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.1 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.2 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.1 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.0 |
0.2 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.5 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.3 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.1 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.0 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
1.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
0.1 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 |
0.0 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 |
0.1 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0098704 |
fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.0 |
0.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.1 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 |
0.1 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.0 |
GO:0033685 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.0 |
0.3 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.2 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.4 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:0046189 |
phenol-containing compound biosynthetic process(GO:0046189) |
| 0.0 |
0.2 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.0 |
0.3 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.0 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.1 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 |
0.1 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.0 |
0.0 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.0 |
0.0 |
GO:0035700 |
astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 0.0 |
0.0 |
GO:0035640 |
exploration behavior(GO:0035640) locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.1 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.5 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.4 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.3 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
1.0 |
GO:0009583 |
phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
| 0.0 |
0.1 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.1 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.0 |
0.1 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 |
0.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
0.1 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.0 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 |
0.0 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.0 |
0.1 |
GO:0051664 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.0 |
0.0 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.0 |
0.2 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.0 |
0.9 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.4 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.3 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.4 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.0 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.0 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.2 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.0 |
0.1 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.0 |
0.5 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.0 |
0.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.0 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.0 |
0.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.0 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.2 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.0 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.0 |
0.3 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.3 |
GO:0031098 |
stress-activated protein kinase signaling cascade(GO:0031098) |
| 0.0 |
0.0 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 |
0.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.0 |
GO:0046645 |
positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.2 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.4 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.0 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.0 |
0.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.0 |
0.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.0 |
0.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.0 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) epinephrine transport(GO:0048241) |
| 0.0 |
0.1 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.0 |
0.1 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.0 |
0.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.7 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.1 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.0 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.0 |
0.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.0 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 |
0.1 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.2 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.0 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.0 |
0.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.1 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 |
0.0 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 |
0.2 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.0 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.0 |
0.1 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.2 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
